← Leaderboards
Chihiro Sato
Washington University
$2,409,633
Attributed
$2,409,633
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $970.4K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,409,633 · 3
By mechanism
R01$1,504,704 · 1
K01$477,304 · 1
R21$427,625 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- John Morris$91,785,862
- David M Holtzman$51,909,630
- Guojun Bu$30,610,787
- Tammie Lee Smith Benzinger$27,265,928
- Anne Fagan Niven$12,288,829
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposAlzheimerâS Disease BiomarkerCerebrospinal FluidCorticobasal DegenerationTau-1BrainAmyloid Beta-ProteinTau ProteinsBiological MarkersMutation CarrierProtein IsoformsProgressive Supranuclear PalsyTauopathiesS DiseaseSymptomsPhosphorylationNerve DegenerationAmyloidClinical TrialsPathologicMutationCohortDementiaFunctional Disorder
Grant awards (8)
Staging primary tauopathies with tau proteoforms$728,653
R01 · FY2025 · AG · contact PI
Staging primary tauopathies with tau proteoforms$776,051
R01 · FY2024 · AG · contact PI
Fluid biomarkers in primary tauopathies$194,375
R21 · FY2024 · AG · contact PI
Fluid biomarkers in primary tauopathies$233,250
R21 · FY2023 · AG · contact PI
Tau Kinetics in the human CNS in vivo and in vitro$119,326
K01 · FY2022 · AG · contact PI
Tau Kinetics in the human CNS in vivo and in vitro$119,326
K01 · FY2021 · AG · contact PI
Tau Kinetics in the human CNS in vivo and in vitro$119,326
K01 · FY2020 · AG · contact PI
Tau Kinetics in the human CNS in vivo and in vitro$119,326
K01 · FY2019 · AG · contact PI